{
  "symbol": "BOLT",
  "company": "Bolt Biotherapeutics, Inc.",
  "generated_at": "2026-06-24T07:36:45.985Z",
  "event_count": 1,
  "events": [
    {
      "type": "scout_dossier",
      "ts": "2026-06-11T20:48:25.926Z",
      "summary": "BOLT is a clinical-stage cancer immunotherapy biotech with ~$23.9M cash (burning ~$8-11M/quarter), facing a going-concern qualification as of Q1 2026 and less than four quarters of runway at current burn rates. A recent cluster of four Form 4 filings (June 10, 2026) for directors LaPorte, Dupont, O'Callaghan, and Onetto triggered the investigation — but all proved to be standard annual board option grants (5,000 shares each at $4.43 strike, vesting June 2027), not open-market purchases. One genuine open-market P-code purchase was found: CEO/President William P. Quinn bought 125 shares on December 5, 2025 at ~$4.607, but this is a de minimis amount (~$576). There are no listed options available and IV cannot be computed. BDC-4182 Phase 1/2 data expected Q3 2026 could serve as a catalyst, but with going-concern risk, near-zero institutional confidence (only 2 analysts), and $22M in net debt, this is an extremely distressed micro-cap with no actionable asymmetric setup.",
      "verdict": "no_anomaly",
      "confidence": 4,
      "tool_calls": 24,
      "walltime_min": 15,
      "debug_path": "dossiers/2026-06-11-BOLT.scout.debug.json"
    }
  ],
  "lessons": [],
  "chart_signal": {
    "ticker": "BOLT",
    "call": "SELL",
    "confidence": 5,
    "score": -8,
    "factors": {
      "below_200dma": "-2",
      "below_50dma": "-1",
      "momentum_down": "-1 (-17.9%)",
      "rsi_neutral": "0 (43)",
      "recent_macd_bearish_cross": "-2 (12d ago)",
      "broken_below_high": "-2 (-39.8% from high)"
    },
    "summary": "SELL (score -8) · 12-1 mom -17.9% · RSI 43 · below_both · -39.8% from high",
    "last_close": 4.26,
    "one_month_ago_close": 4.59,
    "twelve_month_ago_close": 5.59,
    "twelve_one_momentum_pct": -17.89,
    "rsi_14": 43,
    "ma_stack": "below_both",
    "from_period_high_pct": -39.84,
    "period_high": 7.09,
    "price_targets": {
      "bear": 4.96,
      "fair": 16.67,
      "bull": 75,
      "bear_return_pct": 16.4,
      "fair_return_pct": 291,
      "bull_return_pct": 1658.5,
      "method": "street_targets ⨯ chart_floors",
      "street": {
        "target_low": 7,
        "target_mean": 41,
        "target_high": 75,
        "analyst_count": 2
      }
    },
    "generated_at": "2026-06-24T07:36:45.981Z"
  }
}